Survey: Men may not be adequately involved in decisions about prostate cancer screeningSecond study attempts to quantify benefits, risksMen largely make decisions about prostate cancer screening based on conversations with their clinicians, but these discussions often do not include information about the risks of testing in addition to the benefits, according to a report in the September 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. A second report in the same issue uses statistical modeling to estimate the benefits and risks of prostate-specific antigen (PSA) screening in men of various ages and risk levels.The majority of American men older than 50 have been screened with the PSA blood test, according to background information in one of the articles. However,...